found that a TNF-α fusion protein enhanced the effectiveness of immunotherapy through the upregulation of leukocyte-endothelial cell adhesion molecules, the secretion of proinflammatory cytokines and the infiltration of tumor-specific effector CD8+ T cells in tumor-bearing mice (82). This evidence concerns the gene TNF and neoplasm.